Literature DB >> 7388803

Evidence in vivo and in vitro of a role for the pituitary in the growth of malignant lymphomas in Nb rats.

R L Noble, C T Beer, P W Gout.   

Abstract

The growth of a transplantable malignant lymphoma in Nb rats, the Nb 2 node, was accelerated in rats bearing an estrogen pellet and, in particular, in rats bearing transplanted tumors of the anterior pituitary gland. "Lymphoma cell growth-promoting activity" in the sera from the rats was detected and assayed using cultures of Nb 2 node cells. The "activity" of the sera paralleled the degree to which lymphoma growth was accelerated in the animals. Serum from normal rats at a concentration of 1% was moderately active in stimulating culture growth; serum from estrogenized rats was at least 10 times more active; serum from rats bearing pituitary tumors was extremely active and stimulated growth even at a concentration of 0.001% (1:10(5) dilution). In contrast, serum from hypophysectomized rats was devoid of activity, even if the animals were estrogenized. The evidence indicates (a) that the growth of the lymphoma in Nb rats was stimulated by factor(s) in the peripheral blood, the levels of which were subject to control by the pituitary, and (b) that estrogen stimulated lymphoma growth indirectly, through the pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7388803

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Characterization of K+ currents in rat malignant lymphocytes (Nb2 cells).

Authors:  S Cukierman
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

2.  Lymphoid cell-growth hormone interactions: a serum-free model.

Authors:  J E Shaw; R Lang
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

3.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

4.  Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions.

Authors:  G M Gambino; P Beck-Peccoz; S Borgato; G Faglia; A Spada; L Persani
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

5.  The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone.

Authors:  J H Cox; J R Lamb; V Bal; G W Butcher; J C Howard; M J Owen; J Ivanyi
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

6.  Effect of prolactin on DNA methylation in the liver and kidney of rat.

Authors:  P M Reddy; P R Reddy
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

7.  Establishment and control of the L5178Y-cell tumor dormant state in DBA/2 mice.

Authors:  E F Wheelock; M K Robinson; G A Truitt
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

8.  Identification and functional activity of prolactin receptors in thymic epithelial cells.

Authors:  M Dardenne; P A Kelly; J F Bach; W Savino
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

9.  Antigenic, receptor-binding and mitogenic activity of proteolytic fragments of human growth hormone.

Authors:  R Aston; J Ivanyi
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Growth-promoting effect of oestriol in a lymphoma lacking oestrogen receptors.

Authors:  R Kawatsu; T Ezaki; M Kotani; M Akagi
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.